SynthesisFrontiers in immunology2022

Neoadjuvant immune checkpoint inhibitor in combination with chemotherapy or chemoradiotherapy in resectable esophageal cancer: A systematic review and meta-analysis.

He Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.